Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for ABCL

Stock NameAbcellera Biologics Inc
TickerABCL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINCA00288U1066

Show aggregate ABCL holdings

News associated with ABCL

Analysts Set AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target at $8.75
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) has been given a consensus recommendation of “Buy” by the six ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the […] - 2025-08-05 02:08:56
AbCellera Biologics (NASDAQ:ABCL) Reaches New 12-Month High After Analyst Upgrade
Shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday after KeyCorp raised their price target on the stock from $5.00 to $10.00. KeyCorp currently has an overweight rating on the stock. AbCellera Biologics traded as high as $4.40 and last traded at $4.24, with […] - 2025-07-16 02:26:59
AbCellera Biologics (NASDAQ:ABCL) Raised to “Strong-Buy” at Leerink Partnrs
Leerink Partnrs upgraded shares of AbCellera Biologics (NASDAQ:ABCL – Free Report) to a strong-buy rating in a research report sent to investors on Monday,Zacks.com reports. Leerink Partnrs also issued estimates for AbCellera Biologics’ Q2 2025 earnings at ($0.16) EPS, Q3 2025 earnings at ($0.16) EPS, Q4 2025 earnings at ($0.16) EPS, FY2025 earnings at ($0.64) […] - 2025-07-10 03:08:44
Squarepoint Ops LLC Purchases 44,367 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL)
Squarepoint Ops LLC lifted its position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 333.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 57,685 shares of the company’s stock after acquiring an additional 44,367 shares during the quarter. Squarepoint Ops LLC’s holdings in AbCellera Biologics were worth $169,000 as […] - 2025-06-09 04:52:49
AbCellera Biologics Inc. (NASDAQ:ABCL) Stock Position Lifted by Millennium Management LLC
Millennium Management LLC boosted its stake in shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 96.7% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,482,715 shares of the company’s stock after purchasing an additional 728,828 shares during the period. Millennium Management LLC’s holdings in […] - 2025-05-30 04:55:02
AbCellera Biologics (NASDAQ:ABCL) Price Target Cut to $10.00 by Analysts at Truist Financial
AbCellera Biologics (NASDAQ:ABCL – Free Report) had its price target trimmed by Truist Financial from $28.00 to $10.00 in a report released on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts also recently issued reports on the stock. Benchmark reaffirmed a “hold” rating on shares of AbCellera […] - 2025-05-19 02:16:53
Walleye Capital LLC Sells 241,881 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL)
Walleye Capital LLC decreased its position in AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 94.2% during the 4th quarter, Holdings Channel reports. The firm owned 15,000 shares of the company’s stock after selling 241,881 shares during the period. Walleye Capital LLC’s holdings in AbCellera Biologics were worth $44,000 at the end of the most […] - 2025-04-29 05:24:53
Federated Hermes Inc. Reduces Stock Holdings in AbCellera Biologics Inc. (NASDAQ:ABCL)
Federated Hermes Inc. reduced its position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 59.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 916,237 shares of the company’s stock after selling 1,366,459 shares during the quarter. Federated Hermes Inc.’s holdings in AbCellera Biologics were worth $2,685,000 at the end of […] - 2025-04-14 05:15:08
Reviewing AbCellera Biologics (NASDAQ:ABCL) & Intra-Cellular Therapies (NASDAQ:ITCI)
Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) and AbCellera Biologics (NASDAQ:ABCL – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, profitability and earnings. Analyst Recommendations This is a summary of recent […] - 2025-03-11 04:47:14
Benchmark Reaffirms Hold Rating for AbCellera Biologics (NASDAQ:ABCL)
AbCellera Biologics (NASDAQ:ABCL – Get Free Report)‘s stock had its “hold” rating reissued by stock analysts at Benchmark in a research report issued on Monday,Benzinga reports. ABCL has been the subject of a number of other reports. KeyCorp reduced their target price on shares of AbCellera Biologics from $5.00 to $4.00 and set an “overweight” […] - 2025-03-05 04:56:51
AbCellera Biologics Inc. (NASDAQ:ABCL) Short Interest Up 6.8% in January
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 18,430,000 shares, an increase of 6.8% from the January 15th total of 17,260,000 shares. Based on an average daily trading volume, of 3,150,000 […] - 2025-02-17 04:10:55

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ABCL holdings

DateNumber of ABCL Shares HeldBase Market Value of ABCL SharesLocal Market Value of ABCL SharesChange in ABCL Shares HeldChange in ABCL Base ValueCurrent Price per ABCL Share HeldPrevious Price per ABCL Share Held
2025-11-11 (Tuesday)191,905USD 769,539ABCL holding decreased by -3838USD 769,5390USD -3,838 USD 4.01 USD 4.03
2025-11-10 (Monday)191,905ABCL holding increased by 494USD 773,377ABCL holding increased by 24960USD 773,377494USD 24,960 USD 4.03 USD 3.91
2025-11-07 (Friday)191,411USD 748,417ABCL holding decreased by -118675USD 748,4170USD -118,675 USD 3.91 USD 4.53
2025-11-06 (Thursday)191,411ABCL holding increased by 494USD 867,092ABCL holding decreased by -28309USD 867,092494USD -28,309 USD 4.53 USD 4.69
2025-11-05 (Wednesday)190,917USD 895,401ABCL holding decreased by -34365USD 895,4010USD -34,365 USD 4.69 USD 4.87
2025-11-04 (Tuesday)190,917ABCL holding increased by 495USD 929,766ABCL holding decreased by -92800USD 929,766495USD -92,800 USD 4.87 USD 5.37
2025-11-03 (Monday)190,422USD 1,022,566ABCL holding decreased by -34276USD 1,022,5660USD -34,276 USD 5.37 USD 5.55
2025-10-31 (Friday)190,422USD 1,056,842ABCL holding increased by 36180USD 1,056,8420USD 36,180 USD 5.55 USD 5.36
2025-10-30 (Thursday)190,422ABCL holding increased by 2475USD 1,020,662ABCL holding decreased by -35600USD 1,020,6622,475USD -35,600 USD 5.36 USD 5.62
2025-10-29 (Wednesday)187,947ABCL holding increased by 992USD 1,056,262ABCL holding increased by 3705USD 1,056,262992USD 3,705 USD 5.62 USD 5.63
2025-10-28 (Tuesday)186,955USD 1,052,557ABCL holding decreased by -26173USD 1,052,5570USD -26,173 USD 5.63 USD 5.77
2025-10-27 (Monday)186,955USD 1,078,730ABCL holding increased by 20565USD 1,078,7300USD 20,565 USD 5.77 USD 5.66
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ABCL by Blackrock for IE00BYXG2H39

Show aggregate share trades of ABCL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY4944.1903.800 3.839USD 1,896 3.28
2025-11-06BUY4944.7104.370 4.404USD 2,176 3.27
2025-11-04BUY4955.2454.860 4.899USD 2,425 3.25
2025-10-30BUY2,4755.6005.340 5.366USD 13,281 3.22
2025-10-29BUY9925.6205.790 5.773USD 5,727 3.20
2025-10-22SELL-1,9765.4705.660 5.641USD -11,147 3.14 Loss of -4,944 on sale
2025-10-20BUY9885.8606.055 6.035USD 5,963 3.11
2025-10-17BUY2,4675.5905.790 5.770USD 14,235 3.10
2025-10-15BUY3,9286.1006.228 6.215USD 24,413 3.08
2025-10-03BUY3,4655.9006.410 6.359USD 22,034 3.05
2025-10-02BUY4955.9806.210 6.187USD 3,063 3.03
2025-09-30BUY9925.0305.050 5.048USD 5,008 3.01
2025-09-26BUY9924.7404.750 4.749USD 4,711 2.99
2025-09-25BUY9924.6504.720 4.713USD 4,675 2.98
2025-09-24SELL-10,6324.7705.105 5.072USD -53,920 2.97 Loss of -22,394 on sale
2025-09-18BUY5294.7204.790 4.783USD 2,530 2.95
2025-09-17BUY1,5904.5704.800 4.777USD 7,595 2.95
2025-08-20SELL-2,1084.1704.240 4.233USD -8,923 2.91 Loss of -2,786 on sale
2025-07-30BUY2,0964.5704.820 4.795USD 10,050 2.85
2025-07-17SELL-1,0503.9004.130 4.107USD -4,312 2.74 Loss of -1,437 on sale
2025-07-11SELL-4,2164.0104.270 4.244USD -17,893 2.70 Loss of -6,501 on sale
2025-07-07BUY1,5814.0304.115 4.106USD 6,492 2.66
2025-07-02BUY29,0403.7503.770 3.768USD 109,423 2.65
2025-06-20BUY8,4823.4103.545 3.532USD 29,954 2.64
2025-06-11BUY2,0163.2303.570 3.536USD 7,129 2.61
2025-06-04SELL-5072.4202.440 2.438USD -1,236 2.61 Profit of 88 on sale
2025-04-23BUY5022.5302.680 2.665USD 1,338 2.74
2025-04-10SELL-4,0162.0702.120 2.115USD -8,494 2.78 Profit of 2,665 on sale
2025-04-08SELL-5031.9302.140 2.119USD -1,066 2.80 Profit of 340 on sale
2025-04-07SELL-5022.0502.125 2.117USD -1,063 2.80 Profit of 345 on sale
2025-04-04SELL-2,5302.0902.100 2.099USD -5,310 2.81 Profit of 1,805 on sale
2025-04-01BUY2,0642.0902.230 2.216USD 4,574 2.83
2025-03-31SELL-1,5242.2302.260 2.257USD -3,440 2.84 Profit of 882 on sale
2025-03-21BUY9,5752.4402.470 2.467USD 23,622 2.87
2025-03-14SELL-7,6802.5202.595 2.588USD -19,872 2.90 Profit of 2,377 on sale
2025-03-07SELL-9562.3302.410 2.402USD -2,296 2.94 Profit of 516 on sale
2025-03-04SELL-4792.3402.390 2.385USD -1,142 2.97 Profit of 280 on sale
2025-02-25BUY9522.8203.020 3.000USD 2,856 2.99
2025-02-19SELL-4723.4703.550 3.542USD -1,672 2.98 Loss of -266 on sale
2025-02-13BUY1,4133.1403.150 3.149USD 4,450 2.95
2025-02-12BUY4723.1003.110 3.109USD 1,467 2.95
2025-02-11BUY1,8842.9503.020 3.013USD 5,676 2.95
2024-12-30SELL-18,0942.8202.960 2.946USD -53,305 2.83 Loss of -2,050 on sale
2024-11-18SELL-7,8032.6502.710 2.704USD -21,099 2.78 Profit of 613 on sale
2024-11-08SELL-5212.7002.745 2.740USD -1,428 2.78 Profit of 18 on sale
2024-10-21SELL-5252.7702.920 2.905USD -1,525 0.00 Loss of -1,525 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ABCL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,282,76852,836,54145.2%
2025-09-18625,3896,4441,908,97532.8%
2025-09-171,129,48947,2862,469,08245.7%
2025-09-161,139,61256,6913,329,11534.2%
2025-09-15946,4348,9531,844,40251.3%
2025-09-12663,18611,9031,815,31536.5%
2025-09-11801,0145,9002,557,64531.3%
2025-09-10666,8742,4241,976,58133.7%
2025-09-09686,12501,582,06943.4%
2025-09-08705,4631,0531,623,53243.5%
2025-09-05731,2472402,243,92032.6%
2025-09-041,901,32026,1823,669,73351.8%
2025-09-03913,7945,1622,190,19741.7%
2025-09-02809,3122,6001,741,90246.5%
2025-08-29755,1361,6171,665,91545.3%
2025-08-28561,4182,3561,296,81543.3%
2025-08-27441,3445,1001,065,58541.4%
2025-08-26641,2414,3151,470,56143.6%
2025-08-25472,93521,353,42034.9%
2025-08-22623,6435,4042,046,87930.5%
2025-08-21731,13902,456,37029.8%
2025-08-201,060,2156,4303,124,76933.9%
2025-08-19959,9935,9082,859,00333.6%
2025-08-18674,87602,074,32732.5%
2025-08-15857,8491,7832,504,31734.3%
2025-08-141,505,5803993,093,67848.7%
2025-08-13842,23602,960,40528.5%
2025-08-12782,66517,7842,193,00735.7%
2025-08-111,323,899503,545,32437.3%
2025-08-082,570,8728,6536,004,13142.8%
2025-08-071,106,9242,4624,027,90827.5%
2025-08-06757,2951,7752,453,24630.9%
2025-08-05428,2746211,271,02433.7%
2025-08-04529,1707452,069,64725.6%
2025-08-01851,6064143,258,31326.1%
2025-07-31872,7772,9742,683,92232.5%
2025-07-30949,3758031,922,52849.4%
2025-07-291,874,28220,1163,551,33752.8%
2025-07-28690,2497,9011,964,82435.1%
2025-07-25968,29911,9143,083,43331.4%
2025-07-241,063,0578,8042,700,15339.4%
2025-07-23543,2149,5652,454,01022.1%
2025-07-221,006,2971,9623,795,22926.5%
2025-07-214,432,75148,9019,398,52647.2%
2025-07-182,625,04817,8476,240,25142.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.